Angiotech Pharmaceuticals, Inc.
Profile
Mailing Address: 1618 Station Street
Vancouver, British Columbia
V6A 1B6
Head Office Address: 1618 Station Street
Vancouver, British Columbia
V6A 1B6
Contact Name: Carrie Oughton Principal Regulator: British Columbia
Business e-mail address: ir@angio.com Short Form Prospectus Issuer: Yes
Telephone Number: 604 221-6933 Reporting Jurisdictions: Ceased Reporting
Fax Number: Stock Exchange: N/A
Date of Formation: Oct 12 1989 Stock Symbol:
Jurisdiction Where Formed: British Columbia Auditor: PricewaterhouseCoopers LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 034918 Transfer Agent: Computershare Trust Company of Canada
Financial Year-End: Dec 31 Size of Issuer (Assets): Over $1,000,000,000


View This Company's Documents